What Researchers Did
Researchers will conduct a systematic review and meta-analysis to assess the effectiveness and safety of hyperbaric oxygen therapy (HBOT) for patients with fibromyalgia (FM).
What They Found
This is a systematic review protocol, so no findings are available yet. The review plans to search ten databases for randomized controlled trials on hyperbaric oxygen therapy for fibromyalgia published in English or Chinese through December 2022.
What This Means for Canadian Patients
If the completed systematic review finds hyperbaric oxygen therapy to be effective and safe, it could offer a new treatment option for Canadian patients suffering from fibromyalgia. This research could inform clinical guidelines and treatment decisions for managing chronic pain, sleep disturbances, and fatigue associated with FM.
Canadian Relevance
There is no direct Canadian connection mentioned in this study protocol.
Study Limitations
As a systematic review protocol, this study does not present actual patient outcomes or clinical findings at this stage.